NECLIFENSENectar Lifesciences Limited· PharmaceuticalsMinimalNeutral
Announced Sat, 5 Apr · 12:45 IST

Nectar Lifesciences Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

NECLIFE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Nectar Lifesciences Limited has submitted a certificate to the stock exchange as required under SEBI's Depositories and Participants Regulations, 2018. The filing relates to compliance with depository-related rules governing how shares are held and transferred in electronic (demat) form. No financial figures, business updates, or material changes have been disclosed in this announcement. This appears to be a routine procedural submission to maintain regulatory compliance.

Likely market impact

This is a routine compliance filing with no direct impact on the company's financials, operations, or stock price. Shareholders do not need to take any action.